医产联动促进自贸港细胞医疗消费新增长

Group 1 - The core viewpoint emphasizes that this year marks the first year of the closure policy, and the biopharmaceutical industry will continue to innovate and actively expand overseas, leveraging Hainan's biopharmaceutical innovations through the free trade port policy to reach a global market [2] - Hainan is focused on building a modern industrial system with unique characteristics and advantages, presenting new development opportunities for the life and health industry [2] - The proposal includes establishing a "Haikou·Lecheng Cell Therapy Collaborative Innovation Demonstration Model" to promote integrated models of research, preparation, application, and payment for cell therapy [2] Group 2 - The plan suggests creating a dual matching mechanism between clinical demand in Lecheng and technology supply in Haikou, encouraging local quality cell research institutions to apply for new technology applications in Lecheng [2] - Support is proposed for the construction of a provincial-level quality control and standardization center for cell therapy in Haikou, providing GMP-level cell preparation guidance, ethical review consultation, data management, and third-party audit services [2] - The initiative aims to enhance accessibility by including cell therapy research and transformation in existing biopharmaceutical policies and rewarding local enterprises that complete applications in Lecheng [3] Group 3 - The strategy includes creating high-end medical tourism destinations by linking cell therapy with wellness tourism, integrating compliant cell therapy projects into high-end medical services for international tourism consumption [3] - Collaboration between Lecheng and top-tier hospitals in Haikou is encouraged to establish a cell therapy center, aiming to attract global patients for standardized advanced treatments [3]